A trial looking at gefitinib for people with advanced cancer of the food pipe (oesophagus)

Overview

Cancer types:

Oesophageal cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at gefitinib (Iressa) for cancer of the food pipe (oesophageal cancer) that had started to grow again after chemotherapy. This trial was supported by Cancer Research UK.

Recruitment start: 30 March 2009

Recruitment end: 18 November 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor David Ferry

Supported by

AstraZeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

National Institute for Health Research Cancer Research Network (NCRN)

Royal Wolverhampton Hospital NHS Trusts

University of Aberdeen

University of Oxford

Other information

This is Cancer Research UK trial number CRUK/07/017.

Last reviewed: 12 November 2014

CRUK internal database number: 708

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.

A trial looking at gefitinib for people with advanced cancer of the food pipe (oesophagus) - COG Trial